Thymol produces an antidepressant-like effect in a chronic unpredictable mild stress model of depression in mice

Behavioural Brain Research

Volumn 291, Issue , 2015, Pages 12-19

  Deng, Xue Yang ^a   Li, Hong Yan ^a   Chen, Jun Jun ^a   Li, Rui Peng ^a   Qu, Rong ^b   Fu, Qiang ^a   Ma, Shi Ping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Antidepressant; Neurotransmitter; NLRP3; Proinflammatory cytokine; Thymol

Indexed keywords

CORTICOSTERONE; CRYOPYRIN; FLUOXETINE; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MONOAMINE; THYMOL; TUMOR NECROSIS FACTOR ALPHA; ANTIDEPRESSANT AGENT; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; IL1B PROTEIN, MOUSE; INTERLEUKIN-6, MOUSE; NORADRENALIN; SEROTONIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; FORCED SWIM TEST; HIPPOCAMPUS; MALE; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN BRAIN LEVEL; STRESS; SUGAR INTAKE; TAIL SUSPENSION TEST; TREATMENT DURATION; UPREGULATION; WEIGHT REDUCTION; ANIMAL; DEPRESSIVE DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; MENTAL STRESS; METABOLISM; RANDOMIZATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; CARRIER PROTEINS; CASPASE 1; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICE, INBRED ICR; NOREPINEPHRINE; RANDOM ALLOCATION; SEROTONIN; STRESS, PSYCHOLOGICAL; THYMOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929579305     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.04.052     Document Type: Article

References (47)

1. Gao S., Cui Y.L., Yu C.Q., Wang Q.S., Zhang Y. Tetrandrine exerts antidepressant-like effects in animal models: role of brain-derived neurotrophic factor. Behav Brain Res 2013, 238:79-85.
2. Bromet E., Andrade L.H., Hwang I., Sampson N.A., Alonso J., de Girolamo G., et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011, 9:90.
3. Singhal G., Jaehne E.J., Corrigan F., Toben C., Baune B.T. Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci 2014, 8:315.
4. Motivala S.J., Sarfatti A., Olmos L., Irwin M.R. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 2005, 67:187-194.
5. Meyers C.A., Albitar M., Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 2005, 104:788-793.
6. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
7. Miller A.H. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 2009, 23:149-158.
8. Dunn A.J., Swiergiel A.H., de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies. Neurosci Biobehav Rev 2005, 29:891-909.
9. Gadek-Michalska A., Tadeusz J., Rachwalska P., Bugajski J. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep 2013, 65:1655-1662.
10. Iwata M., Ota K.T., Duman R.S. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun 2013, 31:105-114.
11. Davis B.K., Wen H., Ting J.P.-Y. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011, 29:707-735.
12. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
13. Menu P., Vince J.E. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol 2011, 166:1-15.
14. Pan Y., Chen X.Y., Zhang Q.Y., Kong L.D. Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats. Brain Behav Immun 2014, 41:90-100.
15. Alcocer-Gómez E., de Miguel M., Casas-Barquero N., Núñez-Vasco J., Sánchez-Alcazar J.A., Fernández-Rodríguez A., et al. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun 2014, 36:111-117.
16. Alcocer-Gómez E., Cordero M.D. NLRP3 inflammasome: a new target in major depressive disorder. CNS Neurosci Ther 2014, 20:294-295.
17. Costa C., Lodesani M., Maistrello L. Effect of thymol and resveratrol administered with candy or syrup on the development of Nosema ceranae and on the longevity of honeybees (Apis mellifera L.) in laboratory conditions. Apidologie 2010, 41:141-150.
18. Wei Z., Zhou E., Guo C., Fu Y., Yu Y., Li Y., et al. Thymol inhibits Staphylococcus aureus internalization into bovine mammary epithelial cells by inhibiting NF-κB activation. Microb Pathog 2014, 71-72:15-19.
19. Nagoor Meeran M.F., Jagadeesh G.S., Selvaraj P. Thymol attenuates inflammation in isoproterenol induced myocardial infarcted rats by inhibiting the release of lysosomal enzymes and downregulating the expressions of proinflammatory cytokines. Eur J Pharmacol 2015, 754:153-161.
20. Patil D., Dhaneshwar S., Kadam P. Diacerein-thymol prodrug: in vivo release and pharmacological screening in experimental models of osteoarthritis in Wistar rats. Inflamm Allergy Drug Targets 2015, 14:1-12.
21. Zhou E., Fu Y., Wei Z., Yu Y., Zhang X., Yang Z. Thymol attenuates allergic airway inflammation in ovalbumin (OVA)-induced mouse asthma. Fitoterapia 2014, 96:131-137.
22. Deb D.D., Parimala G., Saravana Devi S., Chakraborty T. Effect of thymol on peripheral blood mononuclear cell PBMC and acute promyelotic cancer cell line HL-60. Chem Biol Interact 2011, 193:97-106.
23. Aboelwafa H.R., Yousef H.N. The ameliorative effect of thymol against hydrocortisone-induced hepatic oxidative stress injury in adult male rats. Biochem Cell Biol 2015, 1-8.
24. Azizi Z., Ebrahimi S., Saadatfar E., Kamalinejad M., Majlessi N. Cognitive-enhancing activity of thymol and carvacrol in two rat models of dementia. Behav Pharmacol 2012, 23:241-249.
25. Youdim K.A., Deans S.G. Effect of thyme oil and thymol dietary supplementation on the antioxidant status and fatty acid composition of the ageing rat brain. Br J Nutr 2000, 83:87-93.
26. García D.A., Bujons J., Vale C., Suñol C. Allosteric positive interaction of thymol with the GABAA receptor in primary cultures of mouse cortical neurons. Neuropharmacology 2006, 50:25-35.
27. Marin L.D., Sanchez-Borzone M., Garcia D.A. Comparative antioxidant properties of some GABAergic phenols and related compounds, determined for homogeneous and membrane systems. Med Chem 2011, 7:317-324.
28. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997, 134:319-329.
29. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
30. Haque M.R., Ansari S.H., Najmi A.K., Ahmad M.A. Monoterpene phenolic compound thymol prevents high fat diet induced obesity in murine model. Toxicol Mech Methods 2014, 24:116-123.
31. Em E.S., Ar A.A., Am M., Aa E.A. Thymol and Carvacrol prevent cisplatin-induced nephrotoxicity by abrogation of oxidative stress, inflammation, and apoptosis in rats. J Biochem Mol Toxicol 2015, 29:165-172.
32. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
33. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
34. Frankel A.I., Cook B., Graber J.W., Nalbandov A.V. Determination of corticosterone in plasma by fluorometric techniques. Endocrinology 1967, 80:181-194.
35. McArthur R., Borsini F. Animal models of depression in drug discovery: a historical perspective. Pharmacol Biochem Behav 2006, 84:436-452.
36. Yalcin I., Belzung C., Surget A. Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey. Behav Brain Res 2008, 193:140-143.
37. Pothion S., Bizot J.-C., Trovero F., Belzung C. Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 2004, 155:135-146.
38. Wang Q.S., Tian J.S., Cui Y.L., Gao S. Genipin is active via modulating monoaminergic transmission and levels of brain-derived neurotrophic factor (BDNF) in rat model of depression. Neuroscience 2014, 275:365-373.
39. Zhu C.B., Blakely R.D., Hewlett W.A. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006, 31:2121-2131.
40. Evans J., Sun Y., McGregor A., Connor B. Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology 2012, 63:1315-1326.
41. Wechsler J.B., Hsu C.L., Bryce P.J. IgE-mediated mast cell responses are inhibited by thymol-mediated, activation-induced cell death in skin inflammation. J Allergy Clin Immunol Pract 2014, 133:1735-1743.
42. Fachini-Queiroz F.C., Kummer R., Estevao-Silva C.F., Carvalho M.D., Cunha J.M., Grespan R., et al. Effects of thymol and carvacrol, constituents of Thymus vulgaris L. essential oil, on the inflammatory response. Evid Based Complement Alternat Med 2012, 2012:657026.
43. Riella K.R., Marinho R.R., Santos J.S., Pereira-Filho R.N., Cardoso J.C., Albuquerque-Junior R.L., et al. Anti-inflammatory and cicatrizing activities of thymol, a monoterpene of the essential oil from Lippia gracilis, in rodents. J Ethnopharmacol 2012, 143:656-663.
44. Hosseinimehr S.J., Asadian R., Naghshvar F., Azizi S., Jafarinejad M., Noaparast Z., et al. Protective effects of thymol against nephrotoxicity induced by cisplatin with using 99mTc-DMSA in mice. Ren Fail 2015, 37:280-284.
45. Gholijani N., Gharagozloo M., Farjadian S., Amirghofran Z. Modulatory effects of thymol and carvacrol on inflammatory transcription factors in lipopolysaccharide-treated macrophages. J Immunotoxicol 2015, 1-8.
46. Liang D., Li F., Fu Y., Cao Y., Song X., Wang T., et al. Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-kappaB and MAPK signaling pathways in mouse mammary epithelial cells. Inflammation 2014, 37:214-222.
47. Girotti M., Donegan J.J., Morilak D.A. Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress. Psychoneuroendocrinology 2013, 38:1158-1169.